EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

An Analysis of Adherence to Pharmacotherapy, Effectiveness, Drug Use Pattern and Safety in Systemic Lupus Erythematosus Patients at Tertiary Care Teaching Hospital

Manali Jasvantsinh Zala, Anil Singh, Ridhdhi Hirapara, Payal H. Virani

Apollo Medicine · 30.07.2026

DOI: 10.1177/09760016261466734 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Apollo Medicine, online erschienen am 30.07.2026. Verfasst von Manali Jasvantsinh Zala und 3 weiteren Autor:innen. Die Arbeit nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Aims: Systemic lupus erythematosus (SLE) is a chronic autoimmune disease that needs long-term treatment. Treatment success depends on the effectiveness of these medications and how well patients follow their treatment plans. This research aims to fill this gap by assessing whether there is an association between treatment adherence and the effectiveness of the treatment. To evaluate adherence to pharmacotherapy, treatment effectiveness, drug use patterns and the safety of SLE therapy. Materials and Methods: This was a prospective observational study conducted over 18 months, from February 2023 to July 2024. Patients were followed up at 6 and 12 months. During each visit, they were interviewed in their local language using the Morisky Medication Adherence Scale to assess how well they were following their treatment. The effectiveness of treatment was measured using the SLE disease activity index 2000 (SLEDAI-2K) Responder Index 50 (SRI-50) scale, based on patients’ symptom improvements and lab test results.

Results

A total of 47 patients were included. Over 12 months, low and medium adherence slightly increased, while high adherence decreased. Mean SLEDAI-2K scores improved significantly from 11.6 at baseline to 5.97 at 6 months and 4.63 at 12 months, with 47.36% much improved, 10.52% moderately improved, and 10.52% slightly improved, while 18.42% remained unchanged and only a small proportion worsened. Hydroxychloroquine was most frequently prescribed (95.14%), followed by prednisolone (82.97%), methotrexate (38.29%) and azathioprine (19.14%).

Conclusions

Treatment of SLE showed good effectiveness with a marked reduction in disease activity over 12 months. However, adherence declined slightly.

Zitieren

APA

Zala, M. J., Singh, A., Hirapara, R., & Virani, P. H. (2026). An Analysis of Adherence to Pharmacotherapy, Effectiveness, Drug Use Pattern and Safety in Systemic Lupus Erythematosus Patients at Tertiary Care Teaching Hospital. Apollo Medicine. https://doi.org/10.1177/09760016261466734

Vancouver

Zala MJ, Singh A, Hirapara R, Virani PH. An Analysis of Adherence to Pharmacotherapy, Effectiveness, Drug Use Pattern and Safety in Systemic Lupus Erythematosus Patients at Tertiary Care Teaching Hospital. Apollo Medicine. 2026. doi:10.1177/09760016261466734

BibTeX
@article{Zala2026,
  author = {Zala, Manali Jasvantsinh and Singh, Anil and Hirapara, Ridhdhi and Virani, Payal H.},
  title = {An Analysis of Adherence to Pharmacotherapy, Effectiveness, Drug Use Pattern and Safety in Systemic Lupus Erythematosus Patients at Tertiary Care Teaching Hospital},
  journal = {Apollo Medicine},
  year = {2026},
  doi = {10.1177/09760016261466734}
}
Kostenlos starten →